ADMA BIOLOGICS, INC.
HACKENSACK, NJ · CIK 0001368514 · Biotech · Public
Plasma-derived immunoglobulin and immunotherapy products
admabiologics.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- —
- null offered · none sold
- 165 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 23
- 10 granted · 13 pending
- Sector median: 2
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2969 | The NanoMedicines Innovation Network | — | — |
| 2970 | Kartos Therapeutics | — | — |
| 2971 | CANCURE LLC | — | — |
| 2972 | ADMA BIOLOGICS, INC. | — | — |
| 2973 | Loop East Community Improvement District | — | $1.6M |
| 2974 | ACPHARIS | — | — |
| 2975 | INVVAX, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Steven ElmsDirector
- Bryant FongDirector
- Dov GoldsteinDirector
- Adam GrossmanDirector · Executive Officer
- Jerrold GrossmanDirector
- Lawrence GuiheenDirector
- Brian LenzExecutive Officer
- James MondExecutive Officer
- Eric RichmanDirector
Patents
- Anti-pneumococcal Hyperimmune Globulin For The Treatment And Prevention Of Pneumococcal Infectiongranted
- Compositions And Methods For The Treatment Of Immunodeficiencygranted
- Compositions And Methods For The Treatment Of Immunodeficiencygranted
- Compositions And Methods For Determining Coronavirus Neutralization Titersapplication
- Immunotherapeutic Compositions And Methods Of Production For Coronavirusapplication
- Anti-pneumococcal Hyperimmune Globulin For The Treatment And Prevention Of Pneumococcal Infectiongranted
- Automated Document Management Systemapplication
- Compositions And Methods For The Treatment Of Immunodeficiencygranted
- Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infectiongranted
- Compositions And Methods For The Treatment Of Immunodeficiencygranted
- Compositions And Methods For The Treatment Of Immunodeficiencygranted
- Compositions And Methods For The Treatment Of Immunodeficiencygranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.